Journal article · 2026
Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis
Small, 22(37), e73817 · Published 17 May 2026 · DOI 10.1002/smll.73817
In brief
“Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis” is a 2026 journal article by Mo Chen and 6 co-authors, published in Small. OpenAlex counts 1 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 3.06
- References
- 43
- Authors
- 7
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder driven by systemic inflammation and progressive joint damage. While antigen-specific immune tolerance holds promise as a therapeutic strategy, its clinical translation is hampered by the rapid clearance and unintended immunogenicity associated with conventional antigen delivery. To address these limitations, we developed a tolerogenic nanovaccine (CMLT) that co… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chen, M., Jia, D., Wu, Y., Wang, K., Zhao, X., Guo, X., & Zhou, S. (2026). Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis. Small, 22(37), e73817. https://doi.org/10.1002/smll.73817
MLA 9
Chen, Mo, et al. “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis.” Small, vol. 22, no. 37, 2026, p. e73817. https://doi.org/10.1002/smll.73817.
Chicago
Chen, Mo, Die Jia, Yinlong Wu, Ke Wang, Xing Zhao, Xing Guo, and Shaobing Zhou. 2026. “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis.” Small 22 (37): e73817. https://doi.org/10.1002/smll.73817.
Harvard
Chen, M. et al. (2026) ‘Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis’, Small, 22(37), p. e73817. doi:10.1002/smll.73817.
IEEE
M. Chen et al., “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis,” Small, vol. 22, no. 37, p. e73817, 2026, doi: 10.1002/smll.73817.
BibTeX
@article{chen2026tolerogenic,
title = {{Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis}},
author = {Chen, Mo and Jia, Die and Wu, Yinlong and Wang, Ke and Zhao, Xing and Guo, Xing and Zhou, Shaobing},
journal = {Small},
year = {2026},
volume = {22},
number = {37},
pages = {e73817},
doi = {10.1002/smll.73817},
url = {https://doi.org/10.1002/smll.73817}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- citrullinated peptides
- thrombospondin-1
- lipid nanoparticles
- antigen-specific immunotherapy
- collagen-induced arthritis
- regulatory T cells
- TGF-β1
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Chen, M., Jia, D., Wu, Y., Wang, K., Zhao, X., Guo, X., & Zhou, S. (2026). Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis. Small, 22(37), e73817. https://doi.org/10.1002/smll.73817
How many times has this paper been cited?
1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Mo Chen, Die Jia, Yinlong Wu, Ke Wang, Xing Zhao, Xing Guo, Shaobing Zhou.
What is the DOI of this paper?
10.1002/smll.73817, permanently at https://doi.org/10.1002/smll.73817. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.